Bausch + Lomb Corporation (BLCO) Q2 2026 Earnings Call Transcript

Bausch + Lomb Corporation ( BLCO ) Q2 2026 Earnings Call July 29, 2026 8:00 AM EDT Company Participants George Gadkowski - VP & Head of Investor Relations & Business Insights Brenton L. Saunders - CEO & Chairman Osama Eldessouky - Executive VP & CFO Luc Bonnefoy - President of Surgical Yehia Hashad - Executive VP of Research & Development and Chief Medical officer Conference Call Participants Patrick Wood Young Li - Jefferies LLC, Research Division Lei Huang - Wells Fargo Securities, LLC, Research Division Douglas Miehm - RBC Capital Markets, Research Division Thomas Stephan - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Good morning, and welcome to Bausch + Lomb's Second Quarter 2026 Earnings Call. George Gadkowski VP & Head of Investor Relations & Business Insights Thank you. Good morning, everyone, and welcome to our second quarter 2026 financial results conference call. Participating on today's call are Chairman and Chief Executive Officer, Mr. Brent Saunders; Chief Financial Officer, Mr. Sam Eldessouky; and President of Surgical, Mr. Luc Bonnefoy. In addition to this live webcast, a copy of today's slide presentation and a replay of this conference call will be available on our website under the Investor Relations section. Before we begin, I would like to remind you that our presentation today contains forward-looking information. We would ask that you take a moment to read the forward-looking legend at the beginning of our presentation as it contains important information. This presentation contains non-GAAP financial measures and ratios. For more information about these measures and ratios, please refer to Slide 1 of the presentation. Non-GAAP reconciliations can be found in the appendix to the presentation posted on our